4//SEC Filing
Smith Scott E 4
Accession 0001179110-12-012726
CIK 0001222244other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 3:52 PM ET
Size
21.4 KB
Accession
0001179110-12-012726
Insider Transaction Report
Form 4
Smith Scott E
Director
Transactions
- Award
Stock Options
2012-08-09+25,000→ 25,000 totalExercise: $0.60Exp: 2019-08-09→ Common stock, $0.00001 par value (25,000 underlying)
Holdings
- 171,202
Common stock, $0.0001 par value
- 3,000
Stock Options
Exercise: $7.00Exp: 2013-05-30→ Common Stock, $0.00001 par value (3,000 underlying) - 7,000
Warrants
Exercise: $0.70Exp: 2012-12-31→ Common Stock, $0.00001 par value (7,000 underlying) - 20,000
Stock Options
Exercise: $0.85Exp: 2016-03-03→ Common stock, $0.00001 par value (20,000 underlying) - 14,535
Options
Exercise: $1.72Exp: 2017-08-10→ Common stock $0.00001 par value (14,535 underlying) - 1,000
Stock Options
Exercise: $1.25Exp: 2016-08-11→ Common Stock, $0.00001 par value (1,000 underlying) - 20,000
Warrants
Exercise: $1.30Exp: 2012-11-12→ Common stock, $0.00001 par value (20,000 underlying) - 1,000
Stock Options
Exercise: $1.00Exp: 2015-08-12→ Common stock, $0.00001 par value (1,000 underlying) - 30,000
Stock options
Exercise: $1.50Exp: 2016-09-29→ Common stock, $0.00001 par value (30,000 underlying) - 10,000
Warrants
Exercise: $1.30Exp: 2014-01-07→ Common stock, $0.00001 par value (10,000 underlying) - 32,475
Warrants
Exercise: $1.30Exp: 2013-07-12→ Common stock, $0.00001 par value (32,475 underlying) Convertible Note
Exercise: $1.10Exp: 2012-06-28→ Common stock, $0.00001 par value- 28,736
Stock options
Exercise: $0.87Exp: 2018-08-09→ Common stock, $0.00001 par value (28,736 underlying)
Footnotes (3)
- [F1]Currently exercisable.
- [F2]Annual option award pursuant to the Issuer's compensation policy for Directors upon their re-election to the Board of Directors. The seven-year options vest ratably over 12 months.
- [F3]On December 1, 2011, the reporting person and the Company executed a convertible promissory note in the principal amount of $6,400 with a maturity date of Fenruary 28, 2012. The maturity date was subsequently changed to August 28, 2012. The principal amount and interest accruing at a rate of 10% per year are convertible into common shares at $1.10 per share at any time through the maturity date. The number of shares to be issued upon conversion will be fixed on the conversion date and reported on a Form 4 within 2 business days after conversion. The transaction was approved by the Company's Board of Directors and is exempt under section 16b-3(d).
Documents
Issuer
ProUroCare Medical Inc.
CIK 0001222244
Entity typeother
Related Parties
1- filerCIK 0001364107
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 3:52 PM ET
- Size
- 21.4 KB